You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial
|
|---|---|
| Published in |
Lancet Oncology, July 2019
|
| DOI | 10.1016/s1470-2045(19)30319-5 |
| Pubmed ID | |
| Authors |
Silvia Stacchiotti, Stefano Ferrari, Andres Redondo, Nadia Hindi-Muniz, Emanuela Palmerini, Maria Angeles Vaz Salgado, Anna Maria Frezza, Paolo Giovanni Casali, Antonio Gutierrez, Antonio Lopez-Pousa, Giovanni Grignani, Antoine Italiano, Axel LeCesne, Sarah Dumont, Jean Yves Blay, Nicolas Penel, Daniel Bernabeu, Enrique de Alava, Marie Karanian, Carlo Morosi, Silvia Brich, Gian Paolo Dagrada, Viviana Vallacchi, Chiara Castelli, Monica Brenca, Dominga Racanelli, Roberta Maestro, Paola Collini, Josefina Cruz, Javier Martin-Broto |
X Demographics
The data shown below were collected from the profiles of 36 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 19% |
| Spain | 5 | 14% |
| Germany | 2 | 6% |
| United Kingdom | 2 | 6% |
| Italy | 2 | 6% |
| France | 1 | 3% |
| Taiwan | 1 | 3% |
| Australia | 1 | 3% |
| Portugal | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 14 | 39% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 24 | 67% |
| Practitioners (doctors, other healthcare professionals) | 6 | 17% |
| Science communicators (journalists, bloggers, editors) | 3 | 8% |
| Scientists | 3 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 78 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 18% |
| Student > Ph. D. Student | 10 | 13% |
| Student > Postgraduate | 8 | 10% |
| Other | 5 | 6% |
| Student > Doctoral Student | 4 | 5% |
| Other | 9 | 12% |
| Unknown | 28 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 31 | 40% |
| Biochemistry, Genetics and Molecular Biology | 5 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
| Nursing and Health Professions | 3 | 4% |
| Agricultural and Biological Sciences | 3 | 4% |
| Other | 3 | 4% |
| Unknown | 30 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2020.
All research outputs
#1,062,759
of 25,728,855 outputs
Outputs from Lancet Oncology
#1,262
of 6,937 outputs
Outputs of similar age
#22,409
of 359,350 outputs
Outputs of similar age from Lancet Oncology
#30
of 123 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,937 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.8. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,350 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.